In partnership with
Policy moves fast. We’re faster.
Built by a former cannabis regulator, Policy, Decoded is your high-signal daily briefing for operators, investors, and policymakers navigating the collision of law, regulation, and business.
Before diving into today's intelligence, we want to thank today’s sponsors Go-to-Millions and Masters in Marketing for supporting today’s edition. Our sponsors support the free distribution of this service. Interested in seeing your brand featured in a future policy brief? Reach out!
While you were enjoying your weekend, the cannabis policy landscape shifted dramatically. President Trump's Bedminster dinner comments about marijuana rescheduling sent retail traders into a frenzy, even as former Press Secretary Sean Spicer warned that full legalization "will not happen under this president." Meanwhile, our analysis reveals a coordinated conservative counteroffensive targeting cannabis progress globally, from Germany's CDU pledging rollbacks to MAGA podcasters opposing reform because "everything already smells like weed." Today's intelligence examines why agency reports now sit on the Chief of Staff's desk, how right-wing politicians are weaponizing post-hype industry vulnerability, and what the 32% cannabis price collapse signals about market maturation.
🎯 Watch implementation details.
📊 Ignore retail speculation.
📬 Alert your board.
Start smarter. Move faster. Stay ahead.
Your boss will think you’re a genius
If you’re optimizing for growth, you need ecomm tactics that actually work. Not mushy strategies.
Go-to-Millions is the ecommerce growth newsletter from Ari Murray, packed with tactical insights, smart creative, and marketing that drives revenue.
Every issue is built for operators: clear, punchy, and grounded in what’s working, from product strategy to paid media to conversion lifts.
Subscribe for free and get your next growth unlock delivered weekly.
Start here — the day’s most important development, decoded for impact.
📌 What Happened: President Trump told donors at a $1 million-a-plate Bedminster fundraiser "we need to look at" marijuana rescheduling while White House Chief of Staff Susie Wiles collects agency position reports that "now sit in a report on her desk," according to CNN and Wall Street Journal coverage. The August dinner, attended by Trulieve CEO Kim Rivers, marks Trump's first substantive public comments on cannabis policy since taking office, following months of industry uncertainty over his campaign promises. However, weekend developments revealed conflicting signals as former White House Press Secretary Sean Spicer declared Trump "will not federally legalize marijuana" - "Not under this president," emphasizing the distinction between rescheduling and full legalization. Cannabis stocks surged on retail trading platforms, with Stocktwits showing "extremely bullish" sentiment for Aurora Cannabis, Canopy Growth, and Trulieve, while traders referenced April 2024's 30-40% cannabis rally on similar regulatory speculation (CNN, WSJ, Marijuana Moment, Investing.com).
💡 Why It Matters: The elevated decision-making level and formal agency report compilation indicates rescheduling has moved beyond regulatory bureaucracy to presidential-level political calculus, while Spicer's clarification reveals the administration's careful distinction between modest rescheduling and broader legalization that could alienate conservative constituencies. Weekend retail trading activity demonstrates continued market faith in federal policy catalysts despite fundamentally weak sector performance, with major cannabis companies contributing over $1 million to Trump PACs and paying $300,000 to adviser Alex Bruesewitz for advocacy work. Opposition mobilization by groups like Community Anti-Drug Coalitions of America shows conservative activists recognize the decision's proximity and are pressuring Trump to abandon rescheduling entirely, making the final decision a test of industry lobbying effectiveness versus traditional prohibitionist influence.
🧠 THC Group Take: Trump's willingness to discuss cannabis at a high-dollar fundraiser reveals the issue has transcended traditional political divides, with rescheduling now representing rare bipartisan appeal spanning seniors discovering medical efficacy, nostalgic Boomers, and health-conscious younger generations seeking alcohol alternatives. However, as we've noted previously, this administration's policy priorities originate within the Oval Office, making agency tea leaves useful intelligence but far from definitive regarding presidential intent. Even if Trump delivers a Rose Garden (or is a Rose Patio now?) announcement supporting rescheduling, recall that President Biden made similar public commitments that then disappeared into the grinding machinery of federal bureaucracy for over two years. The critical insight: any Trump announcement must be parsed carefully for implementation specifics rather than broad policy direction, as government will do what it does best - process. Smart operators should prepare for extended bureaucratic timelines, potential legal challenges from prohibition groups, and the possibility that administrative complexity could outlast political enthusiasm, making federal rescheduling a multi-year process regardless of presidential support. The industry's $1M+ investment in Trump's political operation demonstrates serious commitment to securing breakthrough, but the gap between Oval Office intent and regulatory execution remains the fundamental challenge facing federal cannabis reform.
Fast-moving headlines, flagged for what matters.
Suffolk County Sheriff Steven Tompkins faces federal extortion charges for allegedly pressuring Ascend Mass to sell him $50,000 in pre-IPO stock by threatening to revoke a partnership essential to their cannabis licensing application. Tompkins leveraged his Common Ground Institute program, which trains recently released inmates for employment to meet state diversity requirements, as the basis for extorting early stock access from the company seeking regulatory approval. When his stock value declined below the initial investment, Tompkins demanded and received a $50,000 refund through five payments from May 2022 to July 2023, despite having no contractual guarantee for return of principal. The case demonstrates how social equity requirements can create corruption vulnerabilities when public officials control partnerships that companies need for regulatory compliance, potentially turning well-intentioned diversity programs into personal enrichment schemes. Tompkins' arrest follows previous ethics violations and illustrates the broader challenge of preventing public corruption in cannabis licensing processes where regulatory approval depends on demonstrating community partnerships and workforce diversity commitments. (Boston Globe)
Minnesota dispensaries nearing adult-use licenses confront severe product shortages with White Earth Band's Waabigwan Mashkiki serving as the only fully operational legal recreational flower source for state-licensed retailers. Cannabis attorney Jason Tarasek warned industry professionals "We just don't have the product" or infrastructure, despite over 1,000 entrepreneurs holding preliminary microbusiness approvals and only 11 operations fully licensed including five cultivation facilities. The supply bottleneck threatens market launch timing as dispensaries like Minneapolis' Sweetleaves prepare for recreational sales while lacking adequate inventory to meet consumer demand projected to create a $1.2-1.3 billion market by 2028. Minnesota's deliberate exclusion of existing medical marijuana operators from adult-use conversion has created artificial scarcity, forcing reliance on tribal operations and slow-scaling microbusinesses that cannot immediately supply statewide demand. The shortage demonstrates how social equity prioritization and MSO exclusion policies can create operational challenges that delay market functionality despite regulatory readiness, potentially driving continued illicit market participation. (Star Tribune)
Oklahoma Medical Marijuana Authority's new September 5 requirement for license holders to designate an "actively involved" managing owner signals a regulatory crackdown on straw ownership schemes disguised as portal modernization. The mandate requires businesses to appoint a single point of accountability who must personally interface with OMMA rather than allowing representatives, breaking from typical state agency practices that accommodate business counsel and consultants. Industry observers note the timing coincides with Oklahoma's recreational ballot initiative (SQ 837) efforts, suggesting regulators are cleaning house before potential market expansion that could attract federal scrutiny. The move forces out-of-state investors and passive ownership structures to either appoint local managing partners or exit the market, potentially consolidating Oklahoma's oversaturated medical landscape while creating acquisition opportunities for compliant operators. (News 9)
Product support agents and analysts at cannabis software firm Dutchie filed for UFCW Local 1445 union representation, marking a significant labor organizing milestone in the cannabis tech sector that serves over 6,500 dispensaries with 1 million daily transactions. Workers cited concerns about repeated layoffs, inconsistent compensation despite tenure and performance, and the implementation of overseas outsourcing and AI tools that make them feel "like our days are numbered" amid metrics-based micromanagement. The unionization effort reflects broader tech worker organizing trends but carries unique cannabis industry implications as UFCW positions itself as "America's largest cannabis union" seeking to establish labor protections across the expanding sector. Dutchie's central role in cannabis retail infrastructure makes the organizing campaign strategically significant, as successful unionization could influence labor relations across cannabis technology platforms that increasingly control industry operations. The timing amid current "political climate" concerns suggests workers view collective bargaining as essential protection against both industry consolidation and potential federal policy changes affecting cannabis tech employment. (Cannabis Business Times)
Cannabis prices have plummeted 32% since 2021 while consumer prices rose 24%, with Massachusetts ounces dropping from $394 to $145 and Michigan hitting $84 from $419 in 2020, demonstrating that cannabis markets are increasingly responding to normal economic forces despite extraordinary regulatory burdens. The deflationary pressure stems from oversupply in fragmented state markets where operators face Section 280E tax penalties, vertical integration mandates, and state-specific licensing constraints that prevent typical market corrections through interstate commerce. Only 27% of cannabis operators remain profitable according to economist Beau Whitney, yet the price sensitivity to supply-demand dynamics suggests the industry is maturing beyond regulatory artificiality toward standard economic behavior. The contradiction between falling cannabis prices and rising inflation across other sectors reveals how artificial regulatory barriers are preventing cannabis from functioning as a normal commodity, strengthening the economic case for federal normalization that would allow typical market mechanisms to operate. (USA Today/Yahoo Finance)
Cannabis-infused beverage brands are introducing draft THC drinks at bars and taverns, with Pharos Premium Infused Beverages launching kegs of Blood Orange Lime sparkling beverages at Wisconsin venues including Whitetail Inn and Orsetta, while similar offerings appear in South Carolina and Minnesota. The on-tap format creates "sessionable" social experiences that position hemp-derived THC beverages as direct alcohol alternatives, with Pharos co-founder Mary Bernuth describing "a cultural transformation" where consumers explore "new ways to relax, connect, and unwind" through wellness-focused rituals. Draft delivery expands market accessibility within the projected $3.1 billion global cannabis beverage industry by 2030, though federal Farm Bill updates and state-level bans threaten the hemp THC "loophole" enabling these products. The innovation demonstrates how cannabis beverages are evolving beyond packaged products toward traditional hospitality integration, creating new revenue streams for bars while establishing cannabis as mainstream social consumption despite regulatory uncertainty. Pharos advocates for federal regulation treating hemp beverages "like alcohol" with clear labeling and age restrictions rather than prohibition. (Forbes)
Cannabis expungement initiatives reveal fundamental execution gaps threatening long-term market sustainability as 40,000 Americans remain incarcerated for offenses now generating billions in legal revenue. Illinois automatically cleared 700,000 records while California processed 200,000 convictions, yet program complexity and inconsistent implementation expose the disconnect between social equity promises and institutional capacity across legalization states. States with robust expungement infrastructure like New York and Illinois demonstrate measurable community acceptance and regulatory stability, while jurisdictions offering superficial programs face increased advocacy pressure and potential legislative rollbacks from constituencies demanding authentic reform. Sophisticated operators are positioning expungement partnerships as competitive moats rather than regulatory obligations, recognizing that demonstrated social impact creates regulatory sustainability advantages in an industry where community acceptance determines long-term market viability. (Rolling Out)
Retail sentiment turned "extremely bullish" for Aurora Cannabis, Canopy Growth, Cronos Group, and Trulieve after weekend reports of Trump's $1 million-a-plate Bedminster dinner where he signaled interest in rescheduling, with traders referencing April 2024's 30-40% cannabis stock surge on similar regulatory speculation. The Stocktwits activity demonstrates retail investors' continued faith in federal policy catalysts despite fundamentally weak sector performance, with Canopy Growth down 54.4% year-to-date while Aurora gained only 5.4% and Trulieve up 10.5%. One trader noted Aurora's previous rally "to more than $8 a share" during past regulatory optimism, highlighting retail's pattern of chasing policy momentum over operational improvements in a sector plagued by oversupply and profitability challenges. The weekend speculation validates that cannabis stocks remain primarily policy plays rather than fundamental investments, suggesting sophisticated institutional money will wait for concrete regulatory action while retail continues providing volatility-driven liquidity. (Investing.com/Stocktwits)
If you could add one new resource to Policy, Decoded or your toolkit, which would you choose?
- Daily Insider Briefings – rapid, members-only updates with strategic forecasts and next steps.
- Rapid Response War Room – 48-hour turnaround on urgent regulator or policy issues.
- Market Entry Scorecard – state-by-state risk and opportunity ranking.
- Crisis Playbooks – pre-written response templates for deficiency notices, enforcement actions, or PR hits.
- Bill & Regulation Tracker – live dashboard updated weekly with state and federal developments.
The deeper pattern behind today’s moves — and why it matters next.
🧾 Context: Seven years after Canada's 2018 legalization sparked global optimism about inevitable cannabis policy reform, a coordinated right-wing backlash is systematically dismantling that momentum across key markets. Germany's recently elected Christian Democratic Union pledged to overturn 2024 legalization, Canadian Conservative leader Pierre Poilievre promises rollbacks if elected, and MAGA podcaster Charlie Kirk opposes Trump's rescheduling consideration because "everything already smells like weed." The opposition employs fabricated premises, claiming legalization promised immediate black market elimination despite Canada capturing 75% market share in six years when original projections called for decade-long transitions to 80% penetration. Anti-cannabis arguments deliberately conflate cannabis with opioids, exaggerate road safety impacts while ignoring evidence that legalization hasn't increased traffic injuries, and exploit the sector's post-stock-boom vulnerability when institutional investors have moved on to other opportunities.
🔎 What It Signals: The timing reveals strategic political calculation rather than principled opposition, as populist right-wing politicians recognize cannabis industry weakness creates opportunity for prohibition messaging without significant economic or electoral backlash. The coordinated nature across jurisdictions suggests shared polling data showing that cannabis support, while broad, lacks intensity among key right-wing constituencies who prioritize other cultural issues. Most critically, the backlash exposes that legalization momentum was always more fragile than advocates assumed, dependent on continued political goodwill rather than irreversible economic or social integration. Right-wing politicians are betting that cannabis normalization remains incomplete enough that rollback rhetoric energizes their base without alienating moderate voters who view cannabis as a lower-priority issue compared to economic concerns.
🧠 THC Group Take: The right-wing counteroffensive represents an existential threat to cannabis markets precisely because it targets the industry's two most dangerous assumptions: that legalization progress is inevitable and that populist politicians support cannabis for revenue generation. However, the backlash reveals critical strategic blindness about what "legalization" actually means in practice and the consequences of political inaction. Medical cannabis for seniors, veteran access programs, and adult-use markets with social justice frameworks face vastly different political vulnerabilities. Right-wing politicians find it politically costly to oppose medical cannabis for elderly constituents or veteran PTSD treatment, but can easily weaponize adult-use programs that explicitly acknowledge War on Drugs harm to Black and Brown communities and families. This vulnerability was predictable and avoidable - Democrats controlled federal government and numerous states yet failed to advance comprehensive reform, with some Democratic leaders actively opposing ballot initiatives in their own jurisdictions. The industry's current exposure stems from both conflating distinct policy frameworks and ignoring that elections have consequences when potential allies squander political capital. Smart operators must disaggregate their advocacy strategies while recognizing that cannabis policy remains hostage to electoral cycles, making federal normalization before the next political transition essential for protecting existing state markets from coordinated rollback efforts.
How 15 Small Brands Achieved Remarkable Marketing Results
Stop believing you need a big budget to make an impact. Our latest collection highlights 15 small brands that transformed limited resources into significant market disruption through innovative thinking.
Case studies revealing ingenious approaches to common marketing challenges
Practical tactics that delivered 900%+ ROI with minimal investment
Strategic frameworks for amplifying your brand without amplifying your budget
These actionable insights can be implemented immediately, regardless of your team or budget size. See how small brands are making big waves in today's market.
From the hearing room to the comment section — we’re watching it all.
🏭 Rhode Island's Cannabis Control Commission revoked the cultivation license of THCBD, LLC at 49 Mechanic Street in Richmond. Another license bites the dust in the Ocean State's ongoing regulatory tightening. (Providence Journal)
✈️ United pilot with "30 years left" refused to fly SFO-Cancun after passenger smoked weed in first-class lavatory, fearing secondhand exposure could trigger career-ending FAA drug test. Flight delayed 4 hours, passengers got $15 meal vouchers. (View from the Wing)
🌏 Thailand's cannabis reclassification creates regional travel chaos as South Korea conducts "random urine tests on returning citizens" while Singapore, Malaysia, China, and Hong Kong issue advisories against cannabis tourism. 20,000+ Thai cannabis businesses scrambling to comply. (Travel and Tour World)
🚚 Florida deputies stopping U-Haul for "impeding traffic" discovered mobile marijuana farm with oscillating fans, ventilation systems, 47 pounds of processed cannabis, 89 pounds of magic mushrooms, and a 9mm pistol. Peak entrepreneurship meets peak Florida. (CBS12)